---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-304964"
form_type: "8-K"
ticker: "QTTB"
cik: "0001661998"
company_name: "Q32 Bio Inc."
filed_at: "2026-07-15T21:18:59+00:00"
generated_at: "2026-07-15T21:20:05.543890+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Q32 Bio prices $18.25/share offering of 6M shares and pre-funded warrants; net proceeds ~$187.6M

## Summary
- Offering of 6,027,399 shares at $18.25 and pre-funded warrants for 4,931,506 shares at $18.2499.
- Net proceeds estimated at $187.6M (or $215.8M if underwriters' option exercised in full).
- Proceeds for working capital, research, clinical development, and commercialization of bempikibart.
- Underwriters: Morgan Stanley, Jefferies, Cantor Fitzgerald, Oppenheimer; close expected July 16, 2026.
- Pre-funded warrants exercisable at $0.0001/share, subject to ownership limits.

## SEC filing metadata
- accession: 0001193125-26-304964
- form_type: 8-K
- ticker: QTTB
- cik: 0001661998
- company_name: Q32 Bio Inc.
- filed_at: 2026-07-15T21:18:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661998/000119312526304964/0001193125-26-304964-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661998/000119312526304964/d150730d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-304964
- JSON: https://secwatch.observer/filing/0001193125-26-304964.json
- Plain text: https://secwatch.observer/filing/0001193125-26-304964.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.